About: Recommendations from the EGAPP Working Group: can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan?

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Recommendations from the EGAPP Working Group: can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on January 2009

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 2009 (ast) наукова стаття, опублікована в січні 2009 (uk) مقالة علمية نشرت في يناير 2009 (ar) scientific article published on January 2009 (en)
publication date	wds:Q37345971-C7D51FA2-3810-4301-8878-69C20FB9BD75
publication date	2009-01-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37345971-037ADC00-4DD3-45D4-A6E7-CB115198AF95
language of work or name	English
exact match	wds:Q37345971-736923A4-70BA-4EC4-90F0-49F06909615D
exact match	https://scigraph.springernature.com/pub.10.1097/gim.0b013e31818efd9d
cites work	wds:Q37345971-0061F45F-CAF9-432F-8B94-2BC73629671E wds:Q37345971-07E403A7-55BC-489A-B41A-F420A837F7DD wds:Q37345971-0A4DA89D-0C30-4D2C-A400-63B3FF628CFA wds:Q37345971-0CF4C2BC-368F-4C1A-A111-8A9CEF4EF3E1 wds:Q37345971-1BAD85BF-FE1B-4D0F-BEF4-A99265B3F620 wds:Q37345971-1CF932CB-DA45-4DD3-968A-4745DBA9C208 wds:Q37345971-226EED2D-7E34-4BF6-8166-E4B536387351 wds:Q37345971-28136D1E-0CD8-4607-8845-49095CFF2008 wds:Q37345971-2AFCDDF0-81D0-4CE8-8B3A-41EFCAA89E43 wds:Q37345971-2C554B11-A538-4CF1-805A-D8F37112401F wds:Q37345971-360C7E97-8107-4D94-8690-3C452E5AF372 wds:Q37345971-47A5D2AD-8076-49EC-BE47-D6A5799E8C2C wds:Q37345971-47ADF855-E47B-4D28-86FE-5028279224E7 wds:Q37345971-49BCC8B4-190C-4BC7-B994-5635119C64E5 wds:Q37345971-60B432FE-02E2-49E3-B044-BD9147F608A5 wds:Q37345971-6EA4379A-3CC4-4865-9919-4ABC85C7A557 wds:Q37345971-89CCCA27-CD32-4504-BEAF-5EA8AC623757 wds:Q37345971-8A8DB9D0-9973-4ACD-9814-56845D0F60B6 wds:Q37345971-994509D9-561E-4EB6-AEC2-9BABF44BF7D5 wds:Q37345971-AF59A2D8-07CA-4E58-9BD4-9CC32809B7E5 wds:Q37345971-B6DDAD97-D803-4C8F-8C93-25F9421AB0D8 wds:Q37345971-B8F8F4E7-7109-4022-A0AB-38ADCD4D4412 wds:Q37345971-C8878595-062C-47B8-9E49-BFF44A268DE5 wds:Q37345971-D8F611F7-409C-4729-B56A-5DC2821F67CA wds:Q37345971-DAF6A2B0-53B1-4277-B213-C0498720AB19 wds:Q37345971-E647D1E8-12B3-4D3F-8B94-B91AF1F18614 wds:Q37345971-EC28B015-73DF-4DF7-A72F-F9458A2E6ECB wds:Q37345971-F15B648D-2375-446B-A5E8-C970C7313E52 wds:Q37345971-FE9D2305-5BE0-491A-A012-49CA71357C57
cites work	The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: methods of the EGAPP Working Group Can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? An evidence-based review Cancer statistics, 2006 Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan The Role of UGT1A128 Polymorphism in the Pharmacodynamics and Pharmacokinetics of Irinotecan in Patients With Metastatic Colorectal Cancer Management of advanced colorectal cancer: state of the art. Genetic polymorphisms of UDP-glucuronosyltransferases and their functional significance. UGT1A1 gene variations and irinotecan treatment in patients with metastatic colorectal cancer Clinical pharmacokinetics and metabolism of irinotecan (CPT-11). Genetic variation in bilirubin UPD-glucuronosyltransferase gene promoter and Gilbert's syndrome Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes UGT1A128 polymorphism as a determinant of irinotecan disposition and toxicity UGT1A128 genotype and irinotecan-induced neutropenia: dose matters Adjuvant treatment of colorectal cancer Relevance of different UGT1A1 polymorphisms in irinotecan-induced toxicity: a molecular and clinical study of 75 patients UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan Systemic therapy for metastatic colorectal cancer: current options, current evidence UGT1A1 Polymorphism Can Predict Hematologic Toxicity in Patients Treated with Irinotecan Uridine diphosphate glucuronosyl transferase 1A1 promoter polymorphism predicts the risk of gastrointestinal toxicity and fatigue induced by irinotecan-based chemotherapy. Randomized controlled trial of reduced-dose bolus fluorouracil plus leucovorin and irinotecan or infused fluorouracil plus leucovorin and oxaliplatin in patients with previously untreated metastatic colorectal cancer: a North American Intergroup Tri Rapid detection of UGT1A1 gene polymorphisms by newly developed Invader assay Rapid method for detection of extra (TA) in the promoter of the bilirubin-UDP-glucuronosyl transferase 1 gene associated with Gilbert syndrome The role of SN-38 exposure, UGT1A128 polymorphism, and baseline bilirubin level in predicting severe irinotecan toxicity Pharmacogenetics of uridine diphosphoglucuronosyltransferase (UGT) 1A family members and its role in patient response to irinotecan Pharmacogenetics of irinotecan. Weekly regimen of irinotecan/docetaxel in previously treated non-small cell lung cancer patients and correlation with uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) polymorphism Optimal treatment of metastatic colorectal cancer The treatment of advanced colorectal cancer: where are we now and where do we go? Comparison of three methods for genotyping the UGT1A1 (TA)n repeat polymorphism
author name string	wds:Q37345971-E032F6D6-B642-4B81-A471-0E8054102357
author name string	Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group
rdfs:label	Recommendations from the EGAPP Working Group: can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? (en) Recommendations from the EGAPP Working Group: can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? (nl) Recommendations from the EGAPP Working Group: can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? (ast)
skos:prefLabel	Recommendations from the EGAPP Working Group: can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? (en) Recommendations from the EGAPP Working Group: can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? (nl) Recommendations from the EGAPP Working Group: can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? (ast)
name	Recommendations from the EGAPP Working Group: can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? (en) Recommendations from the EGAPP Working Group: can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? (nl) Recommendations from the EGAPP Working Group: can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? (ast)
title	wds:Q37345971-0E1BBFB5-AF47-4D0A-B511-3CDA2AE789C8
title	Recommendations from the EGAPP Working Group: can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? (en)
page(s)	wds:Q37345971-18E98E6A-35E9-4B84-BAA7-972EF6DAC024
page(s)	15-20
instance of	wds:Q37345971-C82786EF-65F5-432C-8E7B-2A0656F38A36
instance of	scholarly article
main subject	wds:Q37345971-0A4EE77D-F466-421F-9D8A-63AAAF2D1BEB wds:Q37345971-28A3D619-E3EC-4419-9C1D-8FFCE45B52B4

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software